Immunologic mechanisms in RCC and allogeneic renal transplant rejection.
The tolerance state that exists between renal cell carcinoma (RCC) and the host's immune system would be an ideal situation in the setting of human kidney transplantation, in which graft tolerance is the ultimate goal of immunosuppressive therapy. On the other hand, acute rejection, as it appears in renal allografts, would be the optimal immunologic situation in patients with RCC. Analysis of the underlying mechanisms of acute allograft rejection and local pro-tumor immunosuppression could help to identify potential therapeutic targets for inducing immune tolerance in allograft recipients and immune rejection in RCC patients. Experimental kidney transplantation might be a suitable model in which to analyze these processes. Macrophages are a prominent and vital cell type in the cellular infiltrate seen in both RCC and renal allografts. Depending on their polarization, they can initiate and promote either proinflammatory or pro-tumor responses, which lead to tissue rejection or acceptance, respectively. Improved understanding of macrophage biology could lead to therapeutic modification of their function in order to promote a desirable immunologic response in either RCC or transplant tissue.
Bedke
Jens
J
Department of Urology, Eberhard Karls University Tübingen, 72076 Tübingen, Germany. bedke@live.com
Stenzl
Arnulf
A
D002292:Carcinoma, Renal Cell / Q000276:immunology* / Q000601:surgery*; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D007680:Kidney Neoplasms / Q000276:immunology* / Q000601:surgery*; D016030:Kidney Transplantation; D008264:Macrophages / Q000276:immunology; D009000:Monocytes / Q000276:immunology; D014181:Transplantation Immunology
Clin Cancer Res. 2008 Dec 15;14(24):8270-8
19088044
Lancet. 2008 Jul 12;372(9633):145-54
18602688
J Gen Physiol. 1927 Mar 7;8(6):519-30
19872213
N Engl J Med. 2000 Sep 14;343(11):750-8
10984562
Transplantation. 2004 May 15;77(9):1319-26
15167584
Cancer Immunol Immunother. 2007 Jan;56(1):117-28
16676181
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4163-70
16857787
BMC Cancer. 2005 May 24;5:51
15910693
Blood. 2007 May 1;109(9):3812-9
17255361
Mol Cancer Ther. 2009 Jul;8(7):1761-71
19567820
Transplantation. 2007 Feb 15;83(3):304-13
17297405
N Engl J Med. 2006 Sep 7;355(10):1018-28
16908486
Nature. 2007 Dec 6;450(7171):903-7
18026089
Jpn J Clin Oncol. 2009 Nov;39(11):745-50
19808839
J Clin Invest. 2007 May;117(5):1155-66
17476345
Eur Urol. 2009 Jun;55(6):1333-42
19201522
Br Med J. 1957 Apr 6;1(5022):779-86
13404306
Nat Immunol. 2002 Nov;3(11):991-8
12407406
Proc Natl Acad Sci U S A. 1977 Apr;74(4):1688-92
300876
Prostate. 2009 Jun 15;69(9):917-27
19267352
N Engl J Med. 1998 Jun 18;338(25):1813-21
9632449
Immunity. 2001 Apr;14(4):377-86
11336683
J Exp Med. 1999 Aug 2;190(3):355-66
10430624
Nat Rev Cancer. 2004 Nov;4(11):891-9
15516961
Lancet. 2001 Jun 2;357(9270):1758-61
11403814
J Immunother. 2008 Jan;31(1):72-80
18157014
Am J Transplant. 2004 Jun;4(6):905-13
15147424
BJU Int. 2009 Feb;103(3):399-405
19021626
J Leukoc Biol. 2009 Nov;86(5):1105-9
19605698
Cancer Sci. 2006 Aug;97(8):780-6
16863511
Int J Cancer. 2006 Dec 15;119(12):2795-802
17019708
J Bioenerg Biomembr. 2007 Jun;39(3):231-4
17551816
Immunogenetics. 2001 Sep;53(7):520-42
11685465
Cancer Immunol Immunother. 2010 May;59(5):687-95
19876628
J Clin Invest. 2005 Dec;115(12):3623-33
16308572
J Exp Med. 1993 Oct 1;178(4):1223-30
8104230
Blood. 1996 Apr 15;87(8):3336-43
8605350
Am J Transplant. 2007 Mar;7(3):527-37
17229070
Med Oncol. 2009;26 Suppl 1:13-7
19148594
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8372-7
12826605
Biochim Biophys Acta. 2009 Aug;1796(1):11-8
19269310
Am J Pathol. 2007 Oct;171(4):1127-39
17702892
Nature. 1999 Feb 11;397(6719):530-4
10028970
J Biol Chem. 2009 Dec 4;284(49):34342-54
19833726
Cancer Res. 1998 Feb 15;58(4):732-6
9485028
Anticancer Res. 2008 Mar-Apr;28(2A):933-41
18507039
J Vasc Res. 2002 Jan-Feb;39(1):51-8
11844937
Cancer. 2007 Dec 15;110(12):2614-27
18000991
J Immunol. 2008 Aug 1;181(3):2220-6
18641362
Transplantation. 2003 Oct 15;76(7):1015-22
14557746
Br J Cancer. 2009 Aug 4;101(3):381-6
19638986
Clin Cancer Res. 2009 Mar 15;15(6):2148-57
19276286
Nat Rev Urol. 2009 Oct;6(10):540-9
19736551
Nat Rev Cancer. 2004 Jul;4(7):540-50
15229479
Curr Opin Immunol. 2008 Apr;20(2):241-6
18508251
J Immunol. 1997 Dec 15;159(12):5834-40
9550379
Clin Exp Nephrol. 2009 Feb;13(1):9-14
19085040
Blood. 2008 Feb 15;111(4):2152-4
18045970
Annu Rev Immunol. 2005;23:515-48
15771580
J Immunol. 2007 Feb 1;178(3):1357-62
17237382
Science. 1991 Dec 13;254(5038):1643-7
1840703
Trends Immunol. 2002 Nov;23(11):549-55
12401408
J Immunother. 2007 Nov-Dec;30(8):825-30
18049334
Leukemia. 2008 Jun;22(6):1226-33
18337760
Clin Genitourin Cancer. 2009 Aug;7(2):E7-9
19692326
Lancet. 2001 Feb 17;357(9255):539-45
11229684
Cancer Res. 2002 Dec 15;62(24):7254-63
12499267
Blood. 2006 Mar 1;107(5):2112-22
16269622
Lancet. 2004 Feb 21;363(9409):594-9
14987883
Nat Rev Cancer. 2009 Jun;9(6):445-52
19461669
Am J Transplant. 2005 Mar;5(3):443-53
15707398
Nat Rev Cancer. 2006 Jan;6(1):24-37
16397525
J Immunol. 2000 Jun 15;164(12):6166-73
10843666
Cancer Res. 2005 Apr 15;65(8):3437-46
15833879
Nature. 2004 Jan 15;427(6971):203-4
14724617
Curr Pharm Des. 2009;15(23):2652-64
19689336
J Clin Invest. 2008 Nov;118(11):3522-30
18982158
Annu Rev Immunol. 2001;19:225-52
11244036
J Urol. 2004 Jun;171(6 Pt 1):2171-5
15126779
Lancet. 2008 Aug 9;372(9637):449-56
18653228
Photochem Photobiol. 2008 Jan-Feb;84(1):10-8
18173696
J Clin Invest. 2005 Aug;115(8):2223-33
16025156
N Engl J Med. 2006 Feb 9;354(6):610-21
16467548
Eur J Immunol. 2010 Jan;40(1):267-78
19830734
FASEB J. 1999 Aug;13(11):1371-83
10428761
Transplantation. 2003 Aug 15;76(3):597-602
12923450
Cancer Res. 2003 Dec 1;63(23):8360-5
14678997
J Immunol. 2006 Nov 15;177(10):7131-8
17082630
Immunol Rev. 2002 Oct;188:164-76
12445290
Annu Rev Immunol. 2009;27:83-117
19007331
Nature. 2007 Nov 22;450(7169):566-9
18033300
J Clin Invest. 2007 May;117(5):1167-74
17476346
Mol Immunol. 2010 Feb;47(5):1047-57
20004976
Eur Urol. 2007 Jun;51(6):1502-10
17408850
J Clin Invest. 1998 Mar 15;101(6):1441-52
9502787
Semin Oncol. 2006 Feb;33(1 Suppl 3):S11-6
16516670